Article Versions Notes

Heider F, Haun U, Döring E, Kudolo M, Sessler C, Albrecht W, Laufer S, Koch P. From 2-Alkylsulfanylimidazoles to 2-Alkylimidazoles: An Approach towards Metabolically More Stable p38α MAP Kinase Inhibitors. Molecules. 2017; 22(10):1729. https://doi.org/10.3390/molecules22101729

Heider, Fabian, Urs Haun, Eva Döring, Mark Kudolo, Catharina Sessler, Wolfgang Albrecht, Stefan Laufer, and Pierre Koch. 2017. "From 2-Alkylsulfanylimidazoles to 2-Alkylimidazoles: An Approach towards Metabolically More Stable p38α MAP Kinase Inhibitors" Molecules 22, no. 10: 1729. https://doi.org/10.3390/molecules22101729

Heider, F., Haun, U., Döring, E., Kudolo, M., Sessler, C., Albrecht, W., Laufer, S., & Koch, P. (2017). From 2-Alkylsulfanylimidazoles to 2-Alkylimidazoles: An Approach towards Metabolically More Stable p38α MAP Kinase Inhibitors. Molecules, 22(10), 1729. https://doi.org/10.3390/molecules22101729